Ensign Peak Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.7M | Buy |
|
|||||
|
2025
Q1 | $21.7M | Buy |
|
|||||
|
2024
Q4 | $18M | Sell |
|
|||||
|
2024
Q3 | $22.2M | Buy |
|
|||||
|
2024
Q2 | $17.9M | Sell |
|
|||||
|
2024
Q1 | $12.2M | Sell |
|
|||||
|
2023
Q4 | $16.8M | Buy |
|
|||||
|
2023
Q3 | $10.5M | Buy |
|
|||||
|
2023
Q2 | $8.99M | Buy |
|
|||||
|
2023
Q1 | $7.93M | Buy |
|
|||||
|
2022
Q4 | $8.82M | Buy |
|
|||||
|
2022
Q3 | $7.11M | Sell |
|
|||||
|
2022
Q2 | $5.38M | Buy |
|
|||||
|
2022
Q1 | $5.95M | Sell |
|
|||||
|
2021
Q4 | $6.91M | Sell |
|
|||||
|
2021
Q3 | $31.8M | Sell |
|
|||||
|
2021
Q2 | $29.3M | Buy |
|
|||||
|
2021
Q1 | $23.7M | Buy |
|
|||||
|
2020
Q4 | $14.3M | Sell |
|
|||||
|
2020
Q3 | $16.5M | Buy |
|
|||||
|
2020
Q2 | $11.3M | Buy |
|
|||||
|
2020
Q1 | $4.35M | Buy |
|
|||||
|
2019
Q4 | $540K | Buy |
|